Combination drug for preparing externally-used drug for treating internal hemorrhoids and preparation method of combination drug
A technology of compound medicine and internal hemorrhoids, which is applied in the field of preparation of the medicine, can solve problems such as complex administration methods, anal mass prolapse, and internal dampness in patients, and achieve good therapeutic effects, reduce toxic and side effects, and have good curative effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032]Embodiment one: the preparation of compound medicament
[0033] The invention provides a compound medicament, which comprises 20%-40% of main drug and 60%-80% of matrix in terms of weight percentage.
[0034] In the present invention, the base may be a suppository base or an ointment base.
[0035] Specifically, the main drug in the present invention, by weight percentage, includes 24-26% of keel, 3-5% of Chuanbei, 3-5% of Galla gall, 12-15% of talcum powder, 6-8% of Burnet chinensis, comfrey 4-6%, Panax notoginseng 3-5%, Bletilla striata 3-5%, Borax 12-15%, Dacronine 4-6%, Lidocaine 9-12%, Paraben 0.4-0.7%, Borneol 4-6%.
[0036] Specifically, the suppository base of the present invention is a mixed fatty acid glyceride.
[0037] Specifically, the ointment base in the present invention includes, by weight, 8-10 parts of vaseline, 6-9 parts of lanolin, 1-2 parts of beeswax, and 2-4 parts of yellow wax.
Embodiment 2
[0038] Embodiment two: the preparation of compound medicament
[0039] The invention provides a compound medicament, which comprises 20% main drug and 80% base by weight percentage.
[0040] In the present invention, the base may be a suppository base or an ointment base.
[0041] Preferably, the main drug in the present invention includes 25.5% of keel, 4% of Chuanbei, 4% of Galla gall, 13% of talcum powder, 7% of Burnet, 5% of comfrey, 4% of Panax notoginseng, and Bletilla striata in parts by weight. 4%, borax 13%, dyclonine 4.5%, lidocaine 11%, paraben 0.5%, borneol 4.5%.
[0042] Specifically, the suppository base of the present invention is a mixed fatty acid glyceride.
[0043] Preferably, the ointment base in the present invention comprises 9 parts of vaseline, 7 parts of lanolin, 1 part of beeswax and 3 parts of yellow wax in parts by weight.
Embodiment 3
[0044] Embodiment three: the preparation of compound medicine
[0045] (1) The main drug raw materials, keel, Chuanbei, gallnut, talcum powder, Burnet, comfrey, Panax notoginseng, Bletilla striata, borax, dyclonine, lidocaine, paraben, borneol, selected to remove impurities Grind the fine powder separately, filter through a No. 6 medicine sieve, and mix in proportion;
[0046] (2) Stir the mixed main drug raw material powder prepared in step (1) with the mixed fatty acid glycerides melted to 60°C, pour 2.0-2.5g of each suppository into the suppository mold, open the mold after cooling, and put The prepared suppository can be used after being taken out of the box;
[0047] (3) Heat medical vaseline, lanolin, beeswax, and yellow wax to form a paste, then add the mixed main drug raw material powder prepared in step (2) into the ointment base, and make a paste to prepare an ointment for use.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com